Journal Basic Info
- Impact Factor: 1.809**
- H-Index: 6
- ISSN: 2474-1655
- DOI: 10.25107/2474-1655
Major Scope
- Physical Medicine & Rehabilitation
- Veterinary Sciences
- Sexual Health
- Infectious Disease
- Emergency Medicine and Critical Care
- Diabetology
- Lung Cancer
- Biochemistry and Biostatistics
Abstract
Citation: Ann Clin Case Rep. 2019;4(1):1617.DOI: 10.25107/2474-1655.1617
Pulmonary Sclerosing Hemangioma with Lymph Node Metastasis: A Case Report
Fan Ren, Honglin Zhao, Zihe Zhang, Hongbing Zhang, Xiaoqian Xu, Hongyu Liu, Gang Chen and Jun Chen
Department of Lung Cancer Surgery, Tianjin Medical University General Hospital, China
Health Management Center, Tianjin Medical University General Hospital, China
These authors are equally contributed
PDF Full Text Case Report | Open Access
Abstract:
Pulmonary Sclerosing Hemangioma (PSH) is a relatively rare lung tumor. Most studies suggest that PSH is benign, but some researchers suggest PSH have malignant potential due to company with lymph node metastasis in certain cases. Here, we reported a case of a 30-year-old female with a solitary mass in her left lung. After a left lower lobectomy and systemic lymphadenectomy was performed, the pathological diagnosis of pulmonary sclerosing hemangioma with lymph node metastasis was given. The immunohistochemistry demonstrated the positive expression of TTF1, EMA in the primary site and metastatic lymph node. Furthermore, AKT1 gene mutation was detected in primary tumor by next generation sequencing. The patient has shown no local recurrence or distal disease in a 1-year follow-up period.
Keywords:
Pulmonary sclerosing hemangioma; Lymph node metastasis; AKT1 mutation
Cite the Article:
Ren F, Zhao H, Zhang Z, Zhang H, Xu X, Liu H, et al. Pulmonary Sclerosing Hemangioma with Lymph Node Metastasis: A Case Report. Ann Clin Case Rep. 2019; 4: 1617.